Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000154111 | SCV000203774 | benign | not specified | 2013-03-06 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000154111 | SCV000204346 | benign | not specified | 2012-02-02 | criteria provided, single submitter | clinical testing | Inferred frequency = 157/386 (LMM data) |
Mendelics | RCV000986531 | SCV001135548 | benign | Usher syndrome type 2A | 2019-05-28 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001513475 | SCV001156868 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001513475 | SCV001721094 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000986531 | SCV001750325 | benign | Usher syndrome type 2A | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000154111 | SCV003928757 | benign | not specified | 2023-04-10 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003888598 | SCV004707970 | benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Breakthrough Genomics, |
RCV001513475 | SCV005280581 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000986531 | SCV002090892 | benign | Usher syndrome type 2A | 2019-11-18 | no assertion criteria provided | clinical testing |